IDEXX Laboratories, Inc. (IDXX) earnings: date, estimates, results and stock reactions
Next earnings: Q4 FY2026 on 2027-02-01 (expected, before the open). EPS estimate 3.30, revenue estimate 1.18B.
Over the last 12 reports the stock moved 9.0% on average (either way), rising 9 times and falling 3. EPS beat estimates 12 of 12 times; revenue 9 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-02 | 3.96 | 3.73 | +6.2% | 1.21B | 1.19B | +21.9% |
| Q2 FY2026 | 2026-08-04 | 4.27 | 3.94 | +8.4% | 1.22B | 1.20B | +3.0% |
| Q1 FY2026 | 2026-05-05 | 3.47 | 3.41 | +1.8% | 1.14B | 1.12B | +2.9% |
| Q4 FY2025 | 2026-02-02 | 3.08 | 2.93 | +5.1% | 1.09B | 1.07B | -5.7% |
| Q3 FY2025 | 2025-11-03 | 3.40 | 3.14 | +8.3% | 1.11B | 1.07B | +14.7% |
| Q2 FY2025 | 2025-08-04 | 3.63 | 3.28 | +10.7% | 1.11B | 1.06B | +19.9% |
| Q1 FY2025 | 2025-05-01 | 2.96 | 2.85 | +3.9% | 998.4M | 997.1M | +9.1% |
| Q4 FY2024 | 2025-02-03 | 2.62 | 2.39 | +9.6% | 954.3M | 935.1M | +10.2% |